Yeatman TJ - Search Results

1

HPP1-mediated tumor suppression requires activation of STAT1 pathways.

Elahi A, Zhang L, Yeatman TJ, Gery S, Sebti S, Shibata D. Elahi A, et al. Among authors: yeatman tj. Int J Cancer. 2008 Apr 1;122(7):1567-72. doi: 10.1002/ijc.23202. Int J Cancer. 2008. PMID: 18059030

2

Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.

Irby R, Mao W, Coppola D, Jove R, Gamero A, Cuthbertson D, Fujita DJ, Yeatman TJ. Irby R, et al. Among authors: yeatman tj. Cell Growth Differ. 1997 Dec;8(12):1287-95. Cell Growth Differ. 1997. PMID: 9419417

3

Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential.

Mao W, Irby R, Coppola D, Fu L, Wloch M, Turner J, Yu H, Garcia R, Jove R, Yeatman TJ. Mao W, et al. Among authors: yeatman tj. Oncogene. 1997 Dec 18;15(25):3083-90. doi: 10.1038/sj.onc.1201496. Oncogene. 1997. PMID: 9444956

4

Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes.

Paredes-Zaglul A, Kang JJ, Essig YP, Mao W, Irby R, Wloch M, Yeatman TJ. Paredes-Zaglul A, et al. Among authors: yeatman tj. Clin Cancer Res. 1998 Apr;4(4):879-86. Clin Cancer Res. 1998. PMID: 9563881

5

Role of Src expression and activation in human cancer.

Irby RB, Yeatman TJ. Irby RB, et al. Among authors: yeatman tj. Oncogene. 2000 Nov 20;19(49):5636-42. doi: 10.1038/sj.onc.1203912. Oncogene. 2000. PMID: 11114744 Review.

6

v-Src transformation is mediated through farnesylated proteins.

Teng S, Sun J, Irby R, Hamilton AD, Sebti S, Yeatman TJ. Teng S, et al. Among authors: yeatman tj. J Surg Res. 2001 Aug;99(2):343-6. doi: 10.1006/jsre.2001.6184. J Surg Res. 2001. PMID: 11469908

7

The promise of microarray technology in melanoma care.

Kim CJ, Reintgen DS, Yeatman TJ. Kim CJ, et al. Among authors: yeatman tj. Cancer Control. 2002 Jan-Feb;9(1):49-53. doi: 10.1177/107327480200900107. Cancer Control. 2002. PMID: 11907466 Free article. Review.

8

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.

Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ. Agrawal D, et al. Among authors: yeatman tj. J Natl Cancer Inst. 2002 Apr 3;94(7):513-21. doi: 10.1093/jnci/94.7.513. J Natl Cancer Inst. 2002. PMID: 11929952

9

Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells.

Irby RB, Yeatman TJ. Irby RB, et al. Among authors: yeatman tj. Cancer Res. 2002 May 1;62(9):2669-74. Cancer Res. 2002. PMID: 11980666

10

The future of clinical cancer management: one tumor, one chip.

Yeatman TJ. Yeatman TJ. Am Surg. 2003 Jan;69(1):41-4. Am Surg. 2003. PMID: 12575779 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters